Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT06543927
Eligibility Criteria:
Inclusion Criteria:
* • Patients with CKD who required and are currently receiving anticoagulation therapy according to the last guidelines, like: Patient was diagnosed with acute DVT, and or pulmonary embolism, and or splanchnic venous thrombosis.
Mechanical heart valve,
Prevention of stroke and systemic embolism in nonvalvular AF with at least one stroke risk factor :
* Prior stroke (ischaemic or unknown type), transient ischaemic attack (TIA) or non-central nervous system (CNS) systemic embolism.
* Age ≥ 75 years.
* Hypertension. iv. Diabetes mellitus.
* Heart failure and/ or left ventricular EF ≤ 35%.
* Patients with CKD ( maintenance or not on hemodialysis)
* Willing and agreed to be included in the study
Exclusion Criteria:
* • Significant inherited or acquired bleeding disorder
* Patient with family history of bleeding tendency
* Patient with contraindication to use anticoagulants
* Clinically significant active bleeding
* Hepatic disease with associated coagulopathy including Child-Pugh C
* Lesions or conditions at significant risk of bleeding including intracranial hemorrhage unless under the advice of a neurologist/neurosurgeon
* Pregnancy, and lactating patient or suspected of pregnancy,
* Incapable of consenting
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06543927
Study Brief:
Protocol Section:
NCT06543927